Category Archives

7 Articles

Notice of General Assembly

by EPAGaf 0 Comments

The EURAPAG Board wishes to hereby give notice of its General Assembly meeting on 9th of June 6 PM CET, by on-line (Zoom) platform. All eligible EURAPAG members and Board members are invited to attend.

For further details on the General Assembly, please refer to the statutes section on the website.

BritSPAG are delighted to announce that the Annual Update in PAG 2025 will be held as a face to face meeting.

by EPAGaf 0 Comments

The conference will run over 2 days, Monday 17th and Tuesday 18th March 2025 at Hope Street Hotel in Liverpool

The conference will provide an overview of the current PAG landscape, common to complex PAG conditions and PAG patient engagement in a varied programme of lectures and peer discussion. The diverse range of speakers reflect the multidisciplinary nature of PAG, providing an opportunity to learn from allied healthcare professionals, network with like-minded peers and enhance the care you provide. This course is suitable for the theoretical component of the Paediatric and Adolescent Gynaecology SITM.

Learning objectives:

  • Conduct a paediatric and adolescent gynaecology consultation and examination
  • Manage common conditions in paediatric and adolescent gynaecology
  • Manage early and late puberty, adolescent menstrual dysfunction, polycystic ovarian syndrome
  • Show awareness of challenges and controversies in this age group
  • Understand current management for those with Disorders of Sex Development and Mullerian Anomalies
  • Understand the psychological aspects and the multidisciplinary approach in PAG
  • Be aware of safeguarding issues in PAG and understand about consent and capacity
  • To enhance the care you provide, both in the DGH and in tertiary referral care setting
  • Build up a network of clinicians with likeminded interests

Supports CPD professional development and acts as revalidation evidence. This course provides 10 Hrs training for CPD subject to peer group approval for revalidation purposes

More details, including the programme and how to book can be found here

Spaces are limited and will be available on a first-come-first-served basis. We do not have a virtual option for attending the conference this year.

Prices (including lunch and refreshments on both days):

  • Doctors £390 (inclusive of VAT)
  • Allied health professionals £354 (inclusive of VAT)
  • Students £270 (inclusive of VAT)

Special rate for a room at Hope Street Hotel (with rooms reserved for BritSPAG on Monday 17th March). A booking-code will be e-mailed to you once you have booked your conference ticket.

There will also be opportunity to attend a networking dinner for £72 (inclusive of VAT), this can be booked at the same time as your conference ticket.

One-dose Human Papillomavirus (HPV) vaccine

It is with pleasure that we received recently the new HPV vaccination strategy from the WHO:

One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer

The 4-7 April convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules provide comparable efficacy to the two or three-dose regimens.

SAGE’s review concluded that a single-dose Human Papillomavirus (HPV)vaccine delivers solid protection against HPV, the virus that causes cervical cancer, that is comparable to 2-dose schedules.  This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls.

Often referred to as the ‘silent killer’ and almost entirely preventable, cervical cancer is a disease of inequity of access; the new SAGE recommendation is underpinned by concerns over the slow introduction of the HPV vaccine into immunization programs and overall low population coverage, especially in poorer countries.

More than 95% of cervical cancer is caused by sexually transmitted HPV, which is the fourth most common type of cancer in women globally with 90% of these women living in low- and middle-income countries. “SAGE urges all countries to introduce HPV vaccines and prioritize multi-age cohort catch up of missed and older cohorts of girls. These recommendations will enable more girls and women to be vaccinated and thus preventing them from having cervical cancer and all its consequences over the course of their lifetimes.”

SAGE recommends updating dose schedules for HPV as follows:

one or two-dose schedule for the primary target of girls aged 9-14

one or two-dose schedule for young women aged 15-2O

two doses with a 6-month interval for women older than 21.

Immunocompromised individuals, including those with HIV, should receive three doses if feasible, and if not at least two doses. There is limited evidence regarding the efficacy of a single dose in this group.

The option for a single dose of the vaccine is less costly, less resource intensive and easier to administer. It facilitates implementing catch-up campaigns for multiple age groups, reduces the challenges link ed to tracing girls for their second dose and allows for financial and human resources to be redirected to other health priorities.”

Women with Bleeding Disorders | Micro E-Learning

Women with Bleeding Disorders | Micro E-Learning

by EURAPAG

Many healthcare professionals, including general practitioners, obstetricians and gynaecologists, can play a crucial role in reducing the time to diagnosis of bleeding disorders in women and girls. A multidisciplinary team of experts have developed an accredited micro e-learning programme to increase awareness, knowledge, and understanding of bleeding disorders and their management among healthcare professionals who are the first to see signs and symptoms of bleeding disorders in women and girls.

The programme consists of two short modules. Within each module there is a 2-minute animation video, a downloadable slide set and a flashcard.

Go to
https://www.hemostasisconnect.info 
to access the materials.


The programme has been developed by the following multidisciplinary team of experts:

Prof. Rezan Abdul-Kadir, Obstetrician and Gynaecologist, The Royal Free Foundation Hospital, London, UK
Dr Sarah O’Brien, Paediatric Haematologist, Nationwide Children’s Hospital, Columbus, OH, USA
Dr Karin van Galen, Haematologist, Van Creveldkliniek, UMC Utrecht, Netherland
Dr Michelle Lavin, Haematologist, National Coagulation Centre, St James’ Hospital, Dublin, Ireland
Dr Roseline d’Oiron, Haematologist, Reference Centre for Haemophilia and RBD, Bicêtre Hospital AP-HP and University of Paris-Saclay, Le Kremlin-Bicêtre, France
Debra Pollard, Lead Nurse, Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London, UK

PROF. JAN HOŘEJŠÍ †



horejsibwrahmen

PROF. JAN HOŘEJŠÍ
May 6th, 1940 – November 18th, 2016

On November 18th, 2016, Prof. Jan Horejsi passed away.

Born in Prague, the homeland of Pediatric and Adolescent Gynecology, when Prof. Peter launched his practice, Prof. Horejsi gave a great contribution to our discipline, mainly dealing with genital anomalies.

Former director of the Dept. of Obstetrics and Adult and Pediatric Gynecology at the Charles University of Prague and treasurer of FIGIJ for more than 20 years, he was the main sponsor, founder and first president of EURAPAG, of which he was an active member till the end of his life with the office of Honorary President.

But, mainly, he was a friend of all of us.

Heartfelt Sympathies to his wife, children and grandchildren
from all EURAPAG Board Members.